Hospital sterile processing and responsible device lifecycle planning

Spec Library

Sustainability and lifecycle specs for the Envista installed base

Lifecycle and sustainability reviews for Envista analyzers, sterilizers, and dental systems start from verified site baselines—energy, reprocessing inputs, utilization, and end-of-life routes—not slogans.

Energy Efficiency

Average analyzer and sterilizer kWh per productive cycle reduced through idle-load controls and utilization reporting. Confirm model-specific energy declarations in the technical file.

Reprocessing & Single-use Reduction

AAMI ST91-aligned reusable alternatives documented across a majority of applicable instrument and tray SKUs, with IFU cycle limits and inspection criteria disclosed.

Take-back & Recycling

WEEE-aligned end-of-life routes with UDI deregistration, data sanitization, and parts harvesting evidence for medical electrical equipment.

Example 12-month site scorecard targets

These are educational RFQ planning targets for a single hospital or dental-group program. Establish a verified site baseline before adopting them as contractual commitments; they are not audited Envista corporate ESG results.

Reference frameworks to validate for your market

ISO 14001 environmental management reference RoHS materials reference REACH materials reference WEEE end-of-life reference ISO 17664 processing information reference

Applicability depends on device, configuration, jurisdiction, and current documentation. Request the relevant records before use in a tender.

Two procurement debates that need local evidence

Single-use devices vs reusable instruments

Single-use case: unopened sterile supply can simplify turnover and remove reprocessing variability, while creating recurring material, packaging, and disposal demand.

Reusable case: validated instruments can lower per-use material demand over repeated cycles, while requiring cleaning labor, water, chemistry, inspection, tracking, repair, and cycle-capacity evidence.

Reproducible review: select one high-volume procedure; observe 30 consecutive cases; record opening, unused waste, cleaning minutes, autoclave cycle at 121°C or 134°C where allowed by the current IFU, damage, and disposal mass.

Central laboratory vs POCT for selected assays

Central lab case: higher analytical capability, QC governance, and LOD/CV transparency, with courier and TAT trade-offs.

POCT case: faster bedside decisions for selected analytes, with operator training, QC lockout, and connectivity constraints that must be verified under the intended use.

Reproducible review: define clinical decision threshold, error budget, and LIS result reconciliation before comparing unit cost alone.

Request the Envista Spec Library sustainability pack

We route by product family, market, and procurement stage. Do not submit patient data.

Download Request (PDF pack)